<DOC>
	<DOCNO>NCT00872391</DOCNO>
	<brief_summary>The purpose study assess safety efficacy hypofractionated stereotactic LINAC radiotherapy 10 fraction 6 Gy per fraction 80 % isodose plan target volume ( PTV ) patient uveal melanoma . Patients followed-up 10 year radiotherapy regard local tumor control , visual acuity , secondary complication survival .</brief_summary>
	<brief_title>Hypofractionated Stereotactic Linear Accelerator Radiotherapy Uveal Melanoma</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Uveal Neoplasms</mesh_term>
	<criteria>The initial height melanoma 7 mm high . Juxtapapillary and/or juxtamacular melanoma height 3 mm high central tumor distance optic disc and/or macula 3 mm less . If form conservative treatment melanoma possible . Prior/Concomitant Treatment . Extrascleral tumor extension present . If presence neovascular glaucoma detect treatment . If metastasis detect baseline . Previous participation study investigational drug within 3 month precede day 0 . Pregnant woman allow participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>